Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Interest & Investment Income (2022 - 2025)

Journey Medical (DERM) has disclosed Interest & Investment Income for 4 consecutive years, with $154000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income fell 18.09% year-over-year to $154000.0, compared with a TTM value of $632000.0 through Sep 2025, down 6.92%, and an annual FY2024 reading of $757000.0, up 135.09% over the prior year.
  • Interest & Investment Income was $154000.0 for Q3 2025 at Journey Medical, up from $138000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $217000.0 in Q1 2024 and bottomed at $3000.0 in Q1 2022.
  • Average Interest & Investment Income over 4 years is $105333.3, with a median of $122000.0 recorded in 2023.
  • The sharpest move saw Interest & Investment Income soared 3966.67% in 2023, then tumbled 31.34% in 2025.
  • Year by year, Interest & Investment Income stood at $50000.0 in 2022, then soared by 126.0% to $113000.0 in 2023, then surged by 69.03% to $191000.0 in 2024, then fell by 19.37% to $154000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for DERM at $154000.0 in Q3 2025, $138000.0 in Q2 2025, and $149000.0 in Q1 2025.